-
Document BC CDA ClinicalDocumentDischargeSummary (V3) (2.16.840.1.113883.3.51.60.2.4)
-
BC CDA Ordering Provider (2.16.840.1.113883.3.51.60.1.9.2)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
Entry CDA Place (2.16.840.1.113883.10.12.317)
-
Section BC CDA Allergies and Intolerances Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.8)
-
Entry BC CDA Allergy Concern Act (V3) (2.16.840.1.113883.3.51.60.3.7)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Allergy - Intolerance Observation (V2) (2.16.840.1.113883.3.51.60.3.6)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
-
Entry BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.2.86)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Criticality Observation (2.16.840.1.113883.10.20.22.2.84)
-
Section Hospital Course Section (1.3.6.1.4.1.19376.1.5.3.1.3.5)
-
Section BC CDA Discharge Diagnosis Section (V3) (2.16.840.1.113883.3.51.60.3.19)
-
Entry BC CDA Hospital Discharge Diagnosis (V3) (2.16.840.1.113883.3.51.60.3.18)
-
Entry BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Age Observation (2.16.840.1.113883.10.20.22.2.63)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)
-
Section BC CDA Discharge Medications Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.17)
-
Entry BC CDA Discharge Medication (V2) (2.16.840.1.113883.3.51.60.3.16)
-
Entry BC CDA Medication Activities (V2) (2.16.840.1.113883.3.51.60.3.13)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.2.65)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.2.69)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
-
Entry BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.2.86)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.2.70)
-
Section BC CDA Plan of Treatment Section (V2) (2.16.840.1.113883.3.51.60.3.36)
-
Entry BC CDA Planned Observation (V2) (2.16.840.1.113883.3.51.60.3.29)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Planned Coverage (2.16.840.1.113883.10.20.22.2.126)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Planned Encounter (V2) (2.16.840.1.113883.3.51.60.3.32)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.2.114)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry BC CDA Planned Act (V2) (2.16.840.1.113883.3.51.60.3.31)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Planned Procedure (V2) (2.16.840.1.113883.3.51.60.3.33)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Planned Medication Activity (V2) (2.16.840.1.113883.3.51.60.3.34)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
-
Entry BC CDA Planned Supply (V2) (2.16.840.1.113883.3.51.60.3.35)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Handoff Communication Participants (2.16.840.1.113883.3.51.60.3.37)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Nutrition Recommendation (2.16.840.1.113883.3.51.60.3.38)
-
Entry BC CDA Planned Encounter (V2) (2.16.840.1.113883.3.51.60.3.32)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.2.114)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry BC CDA Planned Medication Activity (V2) (2.16.840.1.113883.3.51.60.3.34)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
-
Entry BC CDA Planned Observation (V2) (2.16.840.1.113883.3.51.60.3.29)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Planned Coverage (2.16.840.1.113883.10.20.22.2.126)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Planned Procedure (V2) (2.16.840.1.113883.3.51.60.3.33)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Planned Supply (V2) (2.16.840.1.113883.3.51.60.3.35)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Planned Act (V2) (2.16.840.1.113883.3.51.60.3.31)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Planned Immunization Activity (2.16.840.1.113883.3.51.60.3.39)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
-
Entry BC CDA Goal Observation (2.16.840.1.113883.3.51.60.3.40)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Entry Reference (2.16.840.1.113883.10.20.22.4.122)
-
Entry Entry Reference (2.16.840.1.113883.10.20.22.4.122)
-
@ BC CDA Goal Observation (2.16.840.1.113883.3.51.60.3.40)
-
Entry Entry Reference (2.16.840.1.113883.10.20.22.4.122)
-
Entry External Document Reference (2.16.840.1.113883.10.20.22.4.115)
-
Section Chief Complaint Section (2.16.840.1.113883.10.20.22.2.45)
-
Section Reason for Visit Section (2.16.840.1.113883.10.20.22.2.46)
-
Section Discharge Diet Section (1.3.6.1.4.1.19376.1.5.3.1.3.33)
-
Section Family History Section (V3) (2.16.840.1.113883.10.20.22.2.15)
-
Entry Family History Organizer (V3) (2.16.840.1.113883.10.20.22.4.45)
-
Entry Family History Observation (V3) (2.16.840.1.113883.10.20.22.4.46)
-
Entry Age Observation (2.16.840.1.113883.10.20.22.4.31)
-
Entry Family History Death Observation (2.16.840.1.113883.10.20.22.4.47)
-
Section Functional Status Section (V2) (2.16.840.1.113883.10.20.22.2.14)
-
Entry Functional Status Organizer (V2) (2.16.840.1.113883.10.20.22.4.66)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Functional Status Observation (V2) (2.16.840.1.113883.10.20.22.4.67)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
-
Entry Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
-
Entry Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
-
Entry Self-Care Activities (ADL and IADL) (2.16.840.1.113883.10.20.22.4.128)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Functional Status Observation (V2) (2.16.840.1.113883.10.20.22.4.67)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
-
Entry Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
-
Entry Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
-
Entry Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
-
Entry Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
-
Entry Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
-
Entry Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Self-Care Activities (ADL and IADL) (2.16.840.1.113883.10.20.22.4.128)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Sensory Status (2.16.840.1.113883.10.20.22.4.127)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
-
Entry Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
-
Entry Cognitive Status Problem Observation (DEPRECATED) (2.16.840.1.113883.10.20.22.4.73)
-
Entry Functional Status Problem Observation (DEPRECATED) (2.16.840.1.113883.10.20.22.4.68)
-
Entry Pressure Ulcer Observation (DEPRECATED) (2.16.840.1.113883.10.20.22.4.70)
-
Section History of Present Illness Section (1.3.6.1.4.1.19376.1.5.3.1.3.4)
-
Section BC CDA Admission Diagnosis Section (V3) (2.16.840.1.113883.3.51.60.3.23)
-
Entry BC CDA Hospital Admission Diagnosis (V3) (2.16.840.1.113883.3.51.60.3.22)
-
Entry BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Age Observation (2.16.840.1.113883.10.20.22.2.63)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)
-
Section BC CDA Admission Medications Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.21)
-
Entry BC CDA Admission Medication (V2) (2.16.840.1.113883.3.51.60.3.20)
-
Entry BC CDA Medication Activities (V2) (2.16.840.1.113883.3.51.60.3.13)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.2.65)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.2.69)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
-
Entry BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.2.86)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.2.70)
-
Section Hospital Consultations Section (2.16.840.1.113883.10.20.22.2.42)
-
Section Hospital Discharge Instructions Section (2.16.840.1.113883.10.20.22.2.41)
-
Section Hospital Discharge Physical Section (1.3.6.1.4.1.19376.1.5.3.1.3.26)
-
Section Hospital Discharge Studies Summary Section (2.16.840.1.113883.10.20.22.2.16)
-
Section BC CDA Immunizations Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.25)
-
Entry BC CDA Immunization Activity (V3) (2.16.840.1.113883.3.51.60.3.24)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.2.65)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.2.69)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
-
Entry BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.2.86)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Immunization Refusal Reason (2.16.840.1.113883.10.20.22.2.92)
-
Entry Substance Administered Act (2.16.840.1.113883.10.20.22.2.76)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
-
Section BC CDA Problem Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.12)
-
Entry BC CDA Problem Concern Act (V3) (2.16.840.1.113883.3.51.60.3.11)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Age Observation (2.16.840.1.113883.10.20.22.2.63)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)
-
Entry Health Status Observation (V2) (2.16.840.1.113883.10.20.22.2.94)
-
Section Procedures Section (entries optional) (V2) (2.16.840.1.113883.10.20.22.2.7)
-
Entry Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
datatypelevel US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
@ Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
-
@ Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
-
Entry Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
-
datatypelevel US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
-
Entry Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
@ Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
-
Entry Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
datatypelevel US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
@ Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
Entry Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
-
datatypelevel US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
-
Entry Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
-
Entry Procedure Activity Observation (V2) (2.16.840.1.113883.10.20.22.4.13)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
datatypelevel US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
Entry Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
@ Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
@ Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
@ Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
-
Entry Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
-
datatypelevel US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
-
Entry Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
Entry Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
datatypelevel US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
@ Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
Entry Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
-
datatypelevel US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
-
Entry Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
-
@ Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
Entry Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
datatypelevel US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
@ Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
Entry Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
-
datatypelevel US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
-
Entry Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
-
Entry Procedure Activity Act (V2) (2.16.840.1.113883.10.20.22.4.12)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
datatypelevel US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
-
Entry Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
-
Entry Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
-
Entry Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
Entry Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.4.37)
-
Entry Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
-
@ Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
@ Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
-
@ Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
-
Entry Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
-
datatypelevel US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
-
Entry Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
-
Entry Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
-
Entry Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
-
Section Review of Systems Section (1.3.6.1.4.1.19376.1.5.3.1.3.18)
-
Section Social History Section (V3) (2.16.840.1.113883.10.20.22.2.17)
-
Entry Social History Observation (V3) (2.16.840.1.113883.10.20.22.4.38)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Pregnancy Observation (2.16.840.1.113883.10.20.15.3.8)
-
Entry Estimated Date of Delivery (2.16.840.1.113883.10.20.15.3.1)
-
Entry Smoking Status - Meaningful Use (V2) (2.16.840.1.113883.10.20.22.4.78)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Tobacco Use (V2) (2.16.840.1.113883.10.20.22.4.85)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
-
Entry Cultural and Religious Observation (2.16.840.1.113883.10.20.22.4.111)
-
Entry Characteristics of Home Environment (2.16.840.1.113883.10.20.22.4.109)
-
Section Vital Signs Section (entries optional) (V3) (2.16.840.1.113883.10.20.22.2.4)
-
Entry Vital Signs Organizer (V3) (2.16.840.1.113883.10.20.22.4.26)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Entry Vital Sign Observation (V2) (2.16.840.1.113883.10.20.22.4.27)
-
notype Author Participation (2.16.840.1.113883.10.20.22.4.119)
-
Section Advance Directives Section (entries optional) (V3) (2.16.840.1.113883.10.20.22.2.48)
-
Section BC CDA Results Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.41)
-
Section BC CDA Complications DS Section (V3) (2.16.840.1.113883.3.51.60.3.15)
-
Entry BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry Age Observation (2.16.840.1.113883.10.20.22.2.63)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)
|